“Successful Utilization of the GLP-1 Receptor Agonist Semaglutide in Treating the Manifestations of Recalcitrant Celiac Disease”, acbr, vol. 9, no. 5, pp. 392–395, Sep. 2025, Accessed: Sep. 17, 2026. Available: https://fortunejournals.org/ojs/index.php/acbr/article/view/15136